Home › Funds › SILVERARC CAPITAL MANAGEMENT, LLC › EVMN
SILVERARC CAPITAL MANAGEMENT, LLC position in EVMN
EVOMMUNE INC · Health Care
SILVERARC CAPITAL MANAGEMENT, LLC reported holding 594,027 shares of EVMN (EVOMMUNE INC) in its Q3 2026 13F filing — a position valued at US$4.9M, representing 0.63% of its reported portfolio and ranking #39 among its reported holdings. SILVERARC CAPITAL MANAGEMENT, LLC first reported this position in Q3 2026.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How SILVERARC CAPITAL MANAGEMENT, LLC's EVMN position evolved
SILVERARC CAPITAL MANAGEMENT, LLC first disclosed a stake in EVMN in Q3 2026 at 594,027 shares (US$4.9M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 594.03K | $4.91M | New |
About EVMN and 13F data
EVMN (EVOMMUNE INC) is a Health Care company. 109 other funds we track also report a position in EVMN — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$46.4M), EQT Fund Management S.a r.l. (US$43.7M), SymBiosis Capital Partners, LLC (US$29.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding EVMN
- RA CAPITAL MANAGEMENT, L.P. 3.49M sh · $46.44M · Q2 2026
- EQT Fund Management S.a r.l. 5.29M sh · $43.68M · Q3 2026
- SymBiosis Capital Partners, LLC 1.28M sh · $29.45M · Q1 2026
- Pivotal bioVenture Partners Investment Advisor LLC 1.93M sh · $25.61M · Q2 2026
- Nan Fung Group Holdings Ltd 1.44M sh · $19.15M · Q2 2026
- Defilade Capital Management, L.P. 793.14K sh · $10.54M · Q2 2026
- Velan Capital Investment Management LP 451.25K sh · $6.00M · Q2 2026
- GREAT POINT PARTNERS LLC 325.00K sh · $4.32M · Q2 2026
- Avidity Partners Management LP 75.00K sh · $996.75K · Q2 2026
- NEXTBio Capital Management LP 119.06K sh · $983.46K · Q3 2026
- Andera Partners 97.36K sh · $804.21K · Q3 2026
More on SILVERARC CAPITAL MANAGEMENT, LLC
FAQ
How long has SILVERARC CAPITAL MANAGEMENT, LLC held EVMN?
SILVERARC CAPITAL MANAGEMENT, LLC has disclosed EVMN holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is SILVERARC CAPITAL MANAGEMENT, LLC's current position in EVMN?
As of Q3 2026, SILVERARC CAPITAL MANAGEMENT, LLC holds 594.03K shares of EVMN (EVOMMUNE INC), valued at $4.91M, representing 0.63% of its reported portfolio and ranking #39.
Has SILVERARC CAPITAL MANAGEMENT, LLC been buying or selling EVMN?
In the latest 13F filing (Q3 2026), SILVERARC CAPITAL MANAGEMENT, LLC newly opened its position in EVMN.
Which other funds hold EVMN?
Other major institutional holders of EVMN include RA CAPITAL MANAGEMENT, L.P., EQT Fund Management S.a r.l., SymBiosis Capital Partners, LLC, among 109 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.